Valtink Monika, Donath Patricia, Engelmann Katrin, Knels Lilla
Institute of Anatomy, Faculty of Medicine Carl Gustav Carus of the TU Dresden, Fetscherstr. 74, 01307, Dresden, Germany.
Department of Ophthalmology, Klinikum Chemnitz gGmbH, Flemmingstr. 2, 09116, Chemnitz, Germany.
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):285-95. doi: 10.1007/s00417-015-3235-4. Epub 2015 Dec 19.
To examine the effects of media and deswelling agents on human corneal endothelial and epithelial cell viability using a previously developed screening system.
The human corneal endothelial cell line HCEC-12 and the human corneal epithelial cell line HCE-T were cultured in four different corneal organ culture media (serum-supplemented: MEM +2 % FCS, CorneaMax®/CorneaJet®, serum-free: Human Endothelial-SFM, Stemalpha-2 and -3) with and without 6 % dextran T500 or 7 % HES 130/0.4. Standard growth media F99HCEC and DMEM/F12HCE-T served as controls. In additional controls, the stress inducers staurosporine or hydrogen peroxide were added. After 5 days in the test media, cell viability was assessed by flow cytometrically quantifying apoptotic and necrotic cells (sub-G1 DNA content, vital staining with YO-PRO-1® and propidium iodide) and intracellular reactive oxygen species (ROS).
The MEM-based media were unable to support HCEC-12 and HCE-T survival under stress conditions, resulting in significantly increased numbers of apoptotic and necrotic cells. HCEC-12 survival was markedly improved in SFM-based media even under staurosporine or hydrogen peroxide. Likewise, HCE-T survival was improved in SFM with or without dextran. The media CorneaMax®, CorneaJet®, and CorneaMax® with HES supported HCEC-12 survival better than MEM-based media, but less well than SFM-based media. HCE-T viability was also supported by CorneaJet®, but not by CorneaMax® with or without HES. Stemalpha-based media were not suitable for maintaining viability of HCEC-12 or HCE-T in the applied cell culture system.
The use of serum-supplemented MEM-based media for corneal organ culture should be discontinued in favour of serum-free media like SFM.
使用先前开发的筛选系统,研究培养基和消肿剂对人角膜内皮细胞和上皮细胞活力的影响。
将人角膜内皮细胞系HCEC-12和人角膜上皮细胞系HCE-T在四种不同的角膜器官培养基(含血清:MEM +2%胎牛血清、CorneaMax®/CorneaJet®,无血清:人内皮细胞无血清培养基、Stemalpha-2和-3)中培养,添加或不添加6%葡聚糖T500或7%羟乙基淀粉130/0.4。标准生长培养基F99HCEC和DMEM/F12HCE-T用作对照。在其他对照中,添加应激诱导剂星形孢菌素或过氧化氢。在测试培养基中培养5天后,通过流式细胞术定量凋亡和坏死细胞(亚G1期DNA含量、用YO-PRO-1®和碘化丙啶进行活细胞染色)以及细胞内活性氧(ROS)来评估细胞活力。
基于MEM的培养基在应激条件下无法支持HCEC-12和HCE-T存活,导致凋亡和坏死细胞数量显著增加。即使在星形孢菌素或过氧化氢存在的情况下,基于SFM的培养基中HCEC-12的存活率也显著提高。同样,无论有无葡聚糖,SFM中HCE-T的存活率都有所提高。CorneaMax®、CorneaJet®以及添加羟乙基淀粉的CorneaMax®培养基对HCEC-12存活的支持优于基于MEM的培养基,但不如基于SFM的培养基。CorneaJet®也能支持HCE-T的活力,但添加或不添加羟乙基淀粉的CorneaMax®则不能。在应用的细胞培养系统中,基于Stemalpha的培养基不适用于维持HCEC-12或HCE-T的活力。
应停止使用含血清的基于MEM的培养基进行角膜器官培养,而应改用无血清培养基,如人内皮细胞无血清培养基。